Banking

Insulet Getting Closer To Key Technical Measure

The Relative Strength (RS) Rating for Insulet (PODD) moved into a new percentile Thursday, as it got a lift from 70 to 74.

When you’re researching the best stocks to buy and watch, keep a close on eye on relative price strength.

IBD’s unique RS Rating identifies technical performance by showing how a stock’s price movement over the last 52 weeks compares to that of the other stocks in our database.

Decades of market research shows that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating in the early stages of their moves. See if Insulet can continue to show renewed price strength and hit that benchmark.


See How IBD Helps You Make More Money In Stocks


Insulet is working on a flat base with a 310.09 buy point. See if the stock can clear the breakout price in volume at least 40% above average.

The company reported -268% earnings growth in its most recent report, while sales growth came in at 16%. The next quarterly numbers are expected on or around Nov. 4.

Insulet earns the No. 36 rank among its peers in the Medical-Products industry group. Align Technology (ALGN) and Bio Rad Labs (BIOB) are also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button
Native News Post